



THE EFFECT OF SMOKING ON SURVIVAL AND BONE LOSS OF IMPLANTS WITH A FLUORIDE-
MODIFIED SURFACE: A 2-YEAR RETROSPECTIVE ANALYSIS OF 1106 IMPLANTS PLACED IN 
DAILY PRACTICE. 
 




Aim:  To compare survival and peri-implant bone loss of implants with a fluoride-modified surface in smokers 
and nonsmokers.  
Materials and Methods: Patient files of all patients referred for implant treatment from November 2004 to 
2007 were scrutinized. All implants were placed by the same experienced surgeon (BC). The only inclusion 
criterion was a follow-up time of at least 2 years. Implant survival and bone loss were assessed by an external 
calibrated examiner (SV) comparing digital peri-apical radiographs taken during recall visits with the post-
operative ones. Implant success was determined according to the international success criteria (Albrektsson et 
al. 1986). Survival of implants installed in smokers and nonsmokers were compared using the log-rank test. 
Both non-parametric tests and fixed model analysis were adopted to evaluate bone loss in smokers and 
nonsmokers.  
Results: 1106 implants in 300 patients (186 females; 114 males) with a mean follow-up of 31 months (SD 7.15; 
range 24-58) were included. 19 implants in 17 patients failed, resulting in an overall survival rate of 98.3% on 
implant level and 94.6% on patient level. After a follow-up period of 2 years, the CSR was 96.7% and 99.1% with 
the patient and implant as statistical unit respectively. Implant survival was significantly higher for nonsmokers 
compared to smokers (implant level p = 0.025; patient level p = 0.017). The overall mean bone loss was 0.34 
mm (n = 1076; SD 0.65; range 0.00-7.10). Smokers lost significantly more bone compared to nonsmokers in the 
maxilla (0.74 mm; SD 1.07 vs 0.33 mm; SD 0.65; p < 0.001), but not in the mandible (0.25mm; SD 0.65 vs 
0.22mm; SD 0.50; p = 0.298).  
Conclusion: The present study is the first to compare peri-implant bone loss in smokers and nonsmokers from 
the time of implant insertion (baseline) to at least 2 years of follow-up. Implants with a fluoride-modified 
surface demonstrated a high survival rate and limited bone loss. However, smokers are at higher risk to 
experience implant failure and more prone to show peri-implant bone loss in the maxilla. Whether this bone 





Smoking is harmful for general health and has been associated with various diseases, such as 
cardiovascular diseases, cancer and respiratory diseases (Fielding et al. 1985; La Vecchia et 
al. 1991; Peto et al. 1996; Millar & Locker 2007). 
Also, the usage of tobacco has an overwhelming impact on oral health and is associated with 
tooth loss, loss of attachment, vertical bone loss, dry socket and impaired wound healing 
after surgery (Meechan et al. 1988; Johnson & Bain 2000; Kornman & Robertson 2000; 
Scabbia et al. 2001; Baljoon et al. 2004; Millar & Locker 2007; Warnakulasuriya et al. 2010). 
Although the mechanisms are not fully understood, wound healing is disturbed due to an 
impaired fibroblast function, less collagen production, an impaired vasculature affecting 
revascularization after surgery  and an impaired polymorphonuclear neutrophilic and 
macrophagal function (Kenney et al. 1977; MacFarlane et al. 1992; Jorgensen et al. 1998; 
Lehr 2000; Palmer et al. 2005). 
 
Smoking is also known to affect the outcome of implant treatment. Several studies reported 
lower survival rates for implants installed in smokers (Bain & Moy 1993; Schwartz-Arad et al. 
2002; Nitzan et al. 2005; Moy et al. 2005; Strietzel et al. 2007; Koldsland et al. 2009; Anner et 
al. 2010). Some studies show that especially the maxilla is more prone to implant failure (De 
Bruyn & Collaert 1994). Most of these are early failures and occur before functional loading 
(De Bruyn & Collaert 1994; Gorman et al. 1994; Lambert et al. 2000). 
Only a limited number of studies, summarized in Table 1, have compared peri-implant bone 
loss in smokers and nonsmokers. Only 1 study failed to show a significant difference (Aalam 
& Nowzari 2005). The other 15 reported significantly better peri-implant bone levels in 
nonsmokers compared to smokers (Haas et al. 1996; Lindquist et al. 1996; Lindquist et al. 
1997; Carlsson et al 2000; Feloutzis et al. 2003; Karoussis et al. 2004; Penarrocha et al. 2004; 
Wennström et al. 2004a; Wennström et al. 2004b; Galindo-Moreno et al. 2005; Nitzan et al. 
2005; Schwartz-Arad et al. 2005; DeLuca & Zarb 2006; Levin et al. 2008; Vandeweghe et al. 
2009).  
The last decade, most of the implant companies changed the implant surface to a 
moderately rough surface in order to enhance the osseointegration process. Fluoride-
modified implants (OsseospeedTM, Astra Tech®, Möldahl, Sweden) are grit-blasted with 
titanium dioxide particles followed by an additional treatment with diluted fluoride acid, 
which results in a nanoscale surface topography (Ellingsen et al. 2004). Results from 
3 
 
experimental studies suggest that osseointegration is enhanced around fluoride-modified 
implant surfaces, especially during the first weeks of healing (Ellingsen et al.2004; Cooper et 
al. 2006; Berglundh et al. 2007). Enhanced osteoblast differentiation (Masaki et al. 2005; Isa 
et al. 2006; Cooper et al. 2006; Stanford et al. 2006; Guo et al. 2007), platelet activation and 
thrombogenic properties (Stanford et al. 2006; Thor et al. 2007) of the fluoride-modified 
surface have been reported. A recent comparative study shows that, despite smoking having 
an adverse effect on peri-implant bone healing, surface topography changes may affect 
bone-to-implant contact (d’Avila et al. 2010). This might have an effect on peri-implant bone 
preservation and thus on the long-term success of dental implants. 
The aim of this study was to evaluate implant survival and peri-implant bone loss of implants 
with a fluoride-modified surface with respect to self-reported smoking habits. 
 MATERIALS & METHODS 
Patient Selection and Clinical procedures 
All patients referred for implant treatment between November 2004 and 2007 were 
scrutinized. Patients were asked for smoking habits as part of the medical anamnesis during 
intake. The only inclusion criterion was a follow-up time of at least 2 years. All implants were 
placed by the same experienced surgeon (BC) in healed ridges. In case of previous tooth 
extraction a healing time of at least 3 months was respected before implant insertion. A 
crestal incision was made in order to raise the flap and implants were installed according to 
the manufacturer’s guidelines. Digital peri-apical radiographs were taken by the surgeon 
immediately after implant insertion (baseline) with commercially available filmholders using 
the parallel long-cone technique in order to visualize the implant threads and marginal bone-
to-implant contact level. Hence bone loss is reported from the time of surgery. After implant 
treatment all patients were scheduled for professional maintenance including radiographic 
follow-up. The frequency and content of professional maintenance was based on the clinical 
situation and adapted to the individual needs of the patients. Basically this implies a recall 
interval of 6 or 12 months during the first years. The final restorations were made by the 
referring dentist.  
All implants with at least 2 years of follow-up and thus participating in the professional 
maintenance recall system were included to evaluate implant survival and peri-implant bone 
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loss. An external examiner from the University of Ghent had access to the patient files. The 
study protocol was approved by the ethical committee of the Ghent University Hospital.  
Examination Criteria and Statistical analysis 
An Implant was considered a failure when it was removed because of implant mobility, loss 
of integration, ongoing bone loss, infection and/or persistent pain or patient discomfort 
(Zarb & Albrektsson 1998). An individual implant was dichotomized as either survival (value 
0) or a failure (value 1) for Kaplan-Meier survival analysis. The log rank test was used to 
compare implant survival in smokers and nonsmokers both with the patient and the implant 
as statistical unit. Peri-implant bone loss was assessed by an external examiner (SV) 
comparing peri-apical radiographs, taken during recall visits, with the post-operative ones 
taken by the surgeon immediately after implant insertion using digital software (Visi-Quick®, 
Amsterdam, The Netherlands) with an accuracy of 0.1 mm (De Bruyn et al. 2008; Collaert & 
De Bruyn. 2008). Care was taken to visualize the implant threads clearly. Marginal bone level 
was determined both at the mesial and distal site of each implant by measuring the distance 
between the reference point (lower border of the smooth implant collar or the uppermost 
point of the microthreaded part) and the marginal bone-to-implant contact (Figure 1). These 
values were averaged to obtain a single value per implant (individual implant bone loss = 
IIBL). The reference point has been described by previous authors, using the same implant 
system (Åstrand et al. 2004, De Bruyn et al. 2008, Collaert & De Bruyn 2008, Van de Velde et 
al. 2010). The patient’s bone loss (PBL) was calculated as the mean value of all IIBL’s. 
Differences between smokers and nonsmokers were evaluated with the Mann-Whitney U-
test. Moreover mixed model analysis was performed to analyze bone loss using PASW 
statistics 18 because of clustering of implants in patients and jaws. Therefore a logarithmic 
transformation of the data was performed to obtain linearity and homoskedasticity of the 
residuals. To evaluate the impact of time on bone loss, the Mann-Whitney U-test was 
adopted. Inter- and intra-examiner reliability was assessed using percent agreement within 
0.2 mm deviation, Spearman correlation coefficient and the Wilcoxon signed ranks test. An 
individual implant was called a success when bone loss was ≤ 1.5 mm during the first year 
and ≤ 0.2 mm additionally per year (Albrektsson et al. 1986).  The Fisher’s exact test was 





In total 300 patients, 186 females and 114 males, with 1106 implants were evaluated (Table 
2). The mean age was 56 years (SD 12.05; range 17-82). Hundred-fifty-seven patients 
received implants in the maxilla and 143 in the mandible.  Twenty-six of them received 
implants in both jaws. Out of 1106 implants, 121 implants supported single crowns, 318 
supported fixed partial dentures, 631 supported fixed cross-arch bridges and 18 supported 
overdentures. An overview of implant length and diameter is shown in table 3.  
 
After a mean follow-up period of 31 months (SD 7.15; range 24-58), 19 implants failed 
(1.7%), resulting in an absolute survival rate of 98.3%. Nine failures occurred before 
prosthetic loading. In total, 17 patients out of 300 (5.6%) experienced implant failure. Table 
4 shows cumulative survival rates (CSR). After a follow-up period of 2 years, the CSR was 
96.7% and 99.1% with the patient and implant as statistical unit respectively.  
 
Of 244 implants installed in 60 smokers, 8 implants (3.3 %) failed; of 849 implants installed in 
235 nonsmokers, 11 implants failed (1.3 %) and of 5 patients with 13 implants, the smoking 
status was seemingly by mistake not registered into the patient record. In the smokers 
group, 1/139 (0.7%) implant failed in the maxilla, whereas 7/105 (6.7%) implants failed in the 
mandible. In the nonsmoking group, 4/502 (0.8%) implants failed in the maxilla and 7/347 
(2.0%) in the mandible. 
In smokers, the mandible was significantly more prone to implant loss compared to the 
maxilla (p = 0.012). This difference could not be found in nonsmokers (p = 0.085). 
Seven out of 60 smokers (11.7%) and 10 out of 235 nonsmokers (4.3%) experienced implant 
failure. In detail analysis showed a significant difference comparing smokers and 
nonsmokers for cumulative failure rates both on patient (p = 0.017) (Figure 2) and implant 
level (p = 0.025) (Figure 3). Table 5 shows that individual cumulative implant failure rates in 
smokers affect only the maxilla. Patient cumulative failure rates were not affected by jaw 
location. 
 
PERI-IMPLANT BONE LOSS 
Out of 1087 surviving implants, 1076 implants in 295 patients had readable radiographs and 
a follow-up of at least 2 years (Table 2). Intra-examiner repeatability on bone loss was high 
(95 % agreement within 0.2 mm deviation; Spearman correlation coefficient 0.925, p < 0.05; 
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Wilcoxon signed ranks test p = 0.673) as was the inter-examiner variability (90 % agreement 
within 0.2mm of deviation; Spearman correlation coefficient 0.912, p < 0.05; Wilcoxon 
signed ranks test p = 0.532). After a mean follow-up of 31 months, the overall mean bone 
loss was 0.34 mm (SD 0.65; range: 0.00 - 7.10) and 0.33 mm (SD 0.54; range: 0.00 – 4.90) 
with the implant and patient as statistical unit respectively. Follow-up time of the individual 
implants did not influence peri-implant bone level changes (p = 0.084). An overview of bone 
loss values is given in Table 6. Individual Implants installed in smokers are significantly more 
prone to experience peri-implant bone loss compared to nonsmokers (p < 0.001) (Figure 4) 
with a significant difference for the maxilla (p < 0.001), but not for the mandible (p = 0,298) 
(Figure 5). 
Implants installed in the maxilla lost significantly more bone compared with those in the 
mandible both for smokers (p < 0.001) and non-smokers (p < 0.001). The same is valid when 
the patient’s bone loss was considered as statistical unit (Table 6). 
This was confirmed after a logarithmic transformation of the data and fixed model analysis  
to correct for clustering of implants in patients and jaws. Results are given in Table 7.  
 
IMPLANT SUCCESS 
Individual implant success was calculated with respect to the follow-up time.  The overall 
success rate, based on radiographs taken between 24 and 58 months after implant insertion 
was 95.0 %. A significant difference was found between smokers (89.6 %) and nonsmokers 
(96.5 %) (p < 0.001). Table 8 gives an overview of success rates for smokers and nonsmokers 
with respect to the jaw. In the maxilla, the success rate was significantly higher for 
nonsmokers (96.8 %) compared to smokers (87.8 %) (p < 0.001). This difference could not be 
found in the mandible (96.2 % vs 92.2 %; p = 0.083). 
If a threshold of < 1 mm or < 2 mm of bone loss is accepted as the criterion for success, an 
overall success rate of 90.6 % and 95.7 % was found respectively. 
DISCUSSION 
This study scrutinized implant outcome in relation to smoking. Given the retrospective study 
design it is based on patient’s records. As such it relies upon the accuracy of the record and 
the self-reported smoking habits of the patients. It is known from clinical studies relating 
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general health issues with smoking, that patients cannot be considered truthful. Some 
patients considerably underreport their smoking behaviour (Kandell et al.2006; Attebring et 
al. 2001) and biochemical techniques are necessary to objectively quantify tobacco usage. 
Therefore a patient was called a smoker when it was written down in the patient file, 
irrespective of the amount of cigarettes consumed on a daily basis. As such, the study makes 
no distinction between heavy or light smokers. Also tobacco usage may change over time, 
but we consider smoking at the time of surgery as the decisive factor influencing peri-
implant bone and soft tissue healing. 
Only a few clinical studies (Donati et al. 2008; Stanford et al. 2008; Toljanic et al. 2008) or 
abstracts (Steveling et al. 2009; Roediger et al. 2009) are available on implants with a 
fluoride-modified surface, showing an implant survival of 94.5 % – 100 %. Grit-blasted 
implants without the additional fluoride modification (TiOblastTM) are well documented and 
show good clinical results with survival rates from 89.7 % -100 % (Cooper et al. 2008; 
Collaert & De Bruyn. 2008; De Bruyn et al. 2008; Al-Nawas et al. 2010). The present study 
reports an absolute survival rate of 98.3% after 24-58 months of follow-up, confirming the 
good results of the aforementioned studies. The cumulative survival calculation shows that 
the majority of the failures occur prior to prosthetic loading, although additional failures do 
occur after 2 years. Controlled long-term clinical trials to give insight in stability and 
prognosis of these novel implant surfaces are still lacking. Additionally this study reflects the 
everyday clinical practice were all implants, placed by one experienced clinician, are 
included. 
The present study shows that smokers are 2.5 times more likely to experience implant 
failure, both on implant and patient level when comparing absolute survival rates. This is in 
accordance with a previous meta-analysis showing a risk of implant failure for smokers of 2.4 
considering all included studies on implant-related data and 2.6 considering all included 
studies on patient-related data (Strietzel et al. 2007). Cumulative survival rates reveal a 4.0 
and 3.3 times higher failure rate for smokers compared to nonsmokers on patient level and 
implant level respectively. In our analysis smokers showed significantly more implant failures 
in the mandible compared with the maxilla (p = 0.012). All of the failures in the mandible 
occurred in the posterior region. One could speculate that this may be caused by the high 
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bone density and deficiency of vascularization known to occur in the posterior mandible, 
especially in elderly and edentulous patients. (Tolstunov 2007). This in combination with the 
negative effect of smoking on soft tissue healing due to an impaired revascularization may 
compromise bone healing after implant insertion, possibly increasing the number of early 
implant failures (Palmer et al. 2005). Additionally, negative effects of smoking on bone 
metabolism and delayed fracture healing are common sense in orthopaedics (Hoogendoorn 
et al. 2002). Smokers require a longer healing time after fractures and will have a higher 
incidence of non-union of broken bones, infection and/or flap necrosis. 
In the present study an overall mean bone loss of 0.34 mm was found with implant insertion 
as baseline value. Recent studies evaluating peri-implant bone level changes around 
implants with a fluoride-modified surface, reported mean bone level changes of 0.25 - 0.50 
mm (Donati et al. 2008; Stanford et al. 2008; Toljanic et al. 2008). In a recent systematic 
review a mean value of 0.25 mm was found (Laurell & Lundgren. 2009) for grit-blasted 
implants without fluoride modification. The included studies reported on bone level changes 
from the time of prosthetic loading or second stage surgery, were the initial bone 
remodeling prior to prosthetic loading is not taken into account. As described by Åstrand 
and co-workers (2004) major changes in peri-implant bone level can take place between 
implant insertion and prosthetic loading. Additionally, Cooper and co-workers (2001) 
concluded that bone loss around early loaded implants amounted to 0.40 mm during the 
first six weeks of loading, while no further bone loss could be observed following the 
subsequent year. One could conclude that if the radiographic analysis is performed many 
months after implant insertion the total bone loss may be underestimated. Hence in the 
present study, a mean bone loss of 0.34 mm from time of implant insertion can be 
considered very successful.  
As smoking is a systemic factor, peri-implant bone loss was analyzed on patient level. 
Moreover, calculation of peri-implant bone loss was also performed with the individual 
implant as statistical unit because a calculation on patient level may hide clinical 
complications when multiple implants are placed (De Bruyn & Collaert 2008; Misch et al. 
2008). In the present study bone loss was 0.33 mm when calculated with the patient as 
statistical unit but the range decreased massively (0.00 – 7.10 mm vs 0.00 – 4.90 mm).  
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Indeed, one implant with extended bone loss can be masked when other implants in the 
same patient present no bone loss at all. Hence calculating individual peri-implant bone loss 
is an appropriate way to evaluate biological complications. 
Findings from the present study show that the mean peri-implant bone loss is higher in 
smokers compared with nonsmokers. This is in accordance with other studies summarized in 
Table 1 whereby 15 out of 16 studies reported a significant difference. In 7 studies out of 16, 
separate values were not reported for smokers and nonsmokers but it was mentioned that a 
significant difference was observed. The difference in the present study was observed in the 
maxilla, but could not be found in the mandible. These results are in accordance with 
previous studies (Haas et al. 1996; Vandeweghe et al. 2009). This leads to the question what 
different effect cigarette smoking can have on the maxilla and the mandible. A possible 
explanation is that the mandible is partially protected by the tongue, preventing direct 
influences from tobacco smoke to the peri-implant tissues (Haas et al. 1996; Vandeweghe et 
al. 2009). This might explain the better results in the mandible, comparable to the results in 
nonsmokers. Moreover it is reasonable to believe, as bone quality is in generally more 
favorable in the mandible (Trulhar et al. 1997), that the maxilla is more subject to the 
pernicious effect of smoking over the years. 
In the present paper an overall success rate of 95 % is found. Only 5 % of the implants lost > 
1.5 mm during the first year of loading and additionally > 0.2 mm per year (Albrektsson et al. 
1986). One should keep in mind that these criteria does not deal with bone remodeling 
before prosthetic loading, probably giving an underestimation of the success rate in this 
study. If we lower the threshold for success to < 1 mm of bone loss as proposed by De Bruyn 
& Collaert (2008), an overall success rate of 90.6 % is found. Recently, implant success was 
defined as < 2.0 mm of bone loss from the time of implant insertion (Misch et al. 2008). A 
success rate of 95.7 % was found according to the latter. Taken into account that different 
baseline values and different success criteria are used in literature, making a comparison 
between studies on implant success is extremely difficult.  
Finally, surface modifications (Degidi et al. 2006; Fischer et al. 2008; Donati et al. 2008; 
Stanford et al. 2008; Toljanic et al. 2008) can influence bone preservation. Despite this 
enhanced outcome, smokers are more likely to experience implant failure and maxillary peri-
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implant bone loss.  A recent comparative, controlled, prospective study by Shibli and co-
workers (2010) comparing bone healing in smokers and nonsmokers around implants with 
an anodized surface showed more marginal bone loss and fibrous tissue in smokers. Also 
bone-to-implant contact and bone density in the threaded area were significantly lower 
compared to nonsmokers. Randomized controlled trials are warranted to investigate the 
effect of surface modifications on long-term bone preservation in smokers. 
CONCLUSION 
The present study is the first to compare peri-implant bone loss in smokers and nonsmokers 
from the time of implant insertion (baseline) to at least 2 years of follow-up. Implants with a 
fluoride-modified surface demonstrated a high survival rate and limited bone loss. However, 
smokers are more prone to experience implant failure and show more peri-implant bone 
loss in the maxilla.  Whether this bone loss is predicting future biological complications 
remains to be evaluated. Prospective studies are required to assess the dose-dependent 
effect of smoking on implant outcomes. In the mean time all patients should be informed 
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Figure 1. Reference point (lower border of the smooth implant collar or the uppermost point of the 




Figure 2. Kaplan-Meier Survival Curve showing estimated implant failures in function of time for 




Figure 3. Kaplan-Meier Survival Curve showing estimated  implant failures in function of time for 




Figure 4. Cumulative percentage of individual peri-implant bone loss based on available radiographs 




Figure 5. Boxplot presenting individual peri-implant bone loss in smokers and nonsmokers after at 
least 2 years, comparing maxilla (n = 492 in nonsmokers; n = 137 in smokers) and mandible (n = 337 




Table 1. Overview of studies comparing peri-implant bone loss is smokers and nonsmokers. * 
Statistically significant difference was found between smokers and nonsmokers. 
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